With mental health issues continuing to make headlines as greater importance is placed on its value towards wellbeing, medtech company Medibio (ASX: MEB) is developing a Software Medical Device for early detection of depressive symptoms. Sleep disorders, their onset, and progression, will be the key depressive symptom being targeted by Medibio’s technology which will be
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.